Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.
A Cancer Research UK-funded study, published in Cell Genomics, reveals that prostate cancer, which affects one in eight men in their lifetime, includes two different subtypes termed evotypes.
Professor Ros Eeles, Professor of Oncogenetics at The Institute of Cancer Research, London, and Honorary Consultant in Clinical Oncology and Cancer Genetics at The Royal Marsden NHS Foundation Trust, said: “This study has utilised the enormous genomic dataset from The Pan Prostate Cancer Group – a powerhouse of information about prostate cancer from around the world. These results will hopefully lead to better treatments for patients, demonstrating the importance of data sharing and team science.”
To read the full article – click here.